Special Issue

Topic: Advances in DNA Damage & Repair and Cancer Drug Resistance

A Special Issue of Cancer Drug Resistance

ISSN 2578-532X (Online)

Submission deadline: 31 Aug 2020

Guest Editor(s)

Dr. Eddy S. Yang
Hazelrig Salter Radiation Oncology Center, 1700 6th Avenue South Birmingham, AL, USA.
Dr. Robert C.A.M. van Waardenburg
Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL, USA.

Special Issue Introduction

With the recent clinical successes of the PARP inhibitors, the DNA repair pathways have come to the forefront as a bona fide target for personalized treatment of cancers with defective homologous recombination repair. Additionally, DNA repair (genome instability) is a well-established hallmark of cancer and can be a means for dictating tumor sensitivity and resistance to traditional treatments such as chemotherapy and radiation. In this Special Issue, we will provide a basic, translational, and clinical overview of the interactions of the various DNA repair pathways as it relates to carcinogenesis, treatment, and biomarker of response.

Keywords

DNA damage response pathways, DNA repair pathways, cellular response to chemotherapeutics, DNA damage response/repair inhibitors, combination therapy, genome instability, immunotherapy

Submission Deadline

31 Aug 2020

Submission Information

For Author Instructions, please refer to https://www.oaepublish.com/cdr/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=cdr&SpecialIssueId=380
Submission Deadline: 31 Aug 2020
Contacts: Susan Song, Assistant Editor, susan@cdrjournal.com

Published Articles

Targeting DNA repair pathways to overcome cancer drug resistance

Open Access Editorial DOI: 10.20517/cdr.2021.80 18 Aug 2021
Views: Downloads:
Download PDF

DNA direct reversal repair and alkylating agent drug resistance

Open Access Review DOI: 10.20517/cdr.2020.113 18 Jun 2021
Views: Downloads:
Download PDF

Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy

Open Access Review DOI: 10.20517/cdr.2020.89 18 Jun 2021
Views: Downloads:
Download PDF

Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia

Open Access Review DOI: 10.20517/cdr.2020.95 18 Mar 2021
Views: Downloads:
Download PDF

Aberrant DNA repair as a potential contributor for the clonal evolution in subsets of anaplastic thyroid carcinomas arising through dedifferentiation: implications for future therapeutic algorithms?

Open Access Commentary DOI: 10.20517/cdr.2020.66 2 Nov 2020
Views: Downloads:
Download PDF

Radiotherapy and the cellular DNA damage response: current and future perspectives on head and neck cancer treatment

Open Access Review DOI: 10.20517/cdr.2020.49 16 Sep 2020
Views: Downloads:
Download PDF
Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/